diente de león

Dandelion (Taraxacum officinale): A Comprehensive Reference

1. Identity and Botanical Classification

Taraxacum officinale (dandelion) is a perennial flowering plant of the Asteraceae family that has spread globally and is well-known for its traditional uses. The Taraxacum genus to which it belongs is a perennial herb comprising numerous species. The accepted binomial is Taraxacum officinale G.H. Weber ex Wiggers. The species name officinale marks it as a plant of the apothecary — a designation the Linnaean system reserved for herbs with an established place in medicine. The generic name Taraxacum is derived from the Greek taraxos (disorder) and akos (remedy), on account of the curative action of the plant, though an alternative derivation from the Greek taraxo ("I have excited") and achos (pain) has also been proposed.

Key identifiers include sesquiterpene lactones, inulin, potassium, polyphenols such as chicoric acid and chlorogenic acid, and triterpenes such as taraxasterol. The plant presents as a rosette of deeply toothed, lance-shaped leaves radiating from a central taproot, topped by a solitary bright yellow composite flower head that matures into the iconic white seed clock.

Parts Used and Common Preparations

All parts of the dandelion — flowers, stems, roots, and leaves — contain valuable bioactive compounds. Currently, all its parts (roots, foliage, and flowers) are commercially available in different pharmacological and supplemental preparations that are suggested to treat some liver, gallbladder, and kidney disorders.

The European Medicines Agency (EMA) has issued Community Herbal Monographs covering two main herbal drug forms. For the leaf (Taraxaci folium), the recognized preparations include: dried leaves (comminuted), liquid extract (DER 1:1, extraction solvent ethanol 25%), and expressed juice from fresh leaves, in liquid dosage forms or as herbal tea for oral use. For the root with herb (Taraxaci radix cum herba), recognized preparations include comminuted dried root with herb, dry extract (DER 5.6–8.4:1, extraction solvent ethanol 60%), liquid extract (DER 1:0.9–1.1, extraction solvent ethanol 30%), liquid extract (DER 0.75:1, extraction solvent ethanol 30%), and expressed juice (DER 1:0.5–0.8) from fresh flowering plant.

Various cultures have brewed the roots to make a slightly sweet and bitter tea or broth, fermented them into a "root beer," and dried, roasted, and ground them into a rich powder for a coffee-like beverage. Others have harvested the young spring leaves to add to soups, juices, and salads.

2. Traditional and Historical Use

Early Records and Chinese Medicine

Native to Asia and Europe, the dandelion has been recorded in ancient writings, and Arabian physicians used the plant in medicine in the tenth and eleventh centuries. The first record of dandelion use in medicinal practices dates back to the Xinxiu or Tang Bencao, one of the oldest medical texts written in the Tang Dynasty (657–659 AD). Since then, it has been used in Traditional Chinese Medicine (TCM) to purify the blood, boost the immune system, and reduce pain.

In China, it has been used for over a thousand years under the name Pu Gong Ying to treat liver, stomach, and breast conditions, while in India's Ayurvedic practice it was employed for cleansing, digestion, and reducing inflammation.

Arabic and Medieval European Use

By the eleventh century, Arabic cultures had adopted dandelion to treat liver and kidney issues. Medieval European herbalists regarded it as a powerful diuretic, which gave rise to the nickname "piss-a-bed," and Arab physicians such as Avicenna also wrote about its benefits. Dandelions, with their roots in ancient Roman times, have long been treasured for their useful properties. Its use persisted through the Middle Ages in Europe, where it was a staple in monastic gardens and apothecaries for its health-supporting qualities.

Central-Eastern European Folk Medicine

Dandelion (Taraxacum sect. Taraxacum, also referred to as Taraxacum officinale F.H. Wiggers coll.), a collective species of perennial herbaceous plants of the Asteraceae family, is commonly considered a weed; however, in the traditional societies of Central-Eastern Europe, it is a source of food and medicinal raw materials. The vast experience of rural communities in Central-Eastern Europe concerning the medicinal applications of common dandelion has developed through centuries.

Indigenous North American Use

The dandelion root played a significant role in the healing practices of Native American tribes. Its medicinal properties were integrated into their spiritual and healing rituals, underscoring its profound cultural significance.

Summary of Traditional Indications by Culture

The Health Canada Natural Health Products Directorate monograph for dandelion records the following traditional indications drawn from established herbal references: traditionally used in Herbal Medicine to increase the amount of urine to achieve flushing of the urinary tract as an adjuvant in minor urinary complaints (EMA 2009); as a diuretic; as a laxative (aperient); to help increase bile flow (choleretic); and to help treat digestive upset (dyspepsia).

The EMA recommends dandelion as a traditional herbal medicinal product for the relief of symptoms associated with mild digestive disorders — such as a feeling of abdominal fullness, flatulence, and slow digestion — and temporary loss of appetite. The European Scientific Cooperative on Phytotherapy (ESCOP) recommends dandelion root for "the restoration of liver and biliary function, dyspepsia and loss of appetite."

3. Key Constituents and Active Compounds

Sesquiterpene Lactones

Sesquiterpene lactones, such as taraxacin and various germacranolides including taraxinic acid and its β-glucopyranosyl ester, are abundant in the roots and leaves, imparting a bitter taste and serving as key identifiers of the species. The Taraxacum genus is abundant in sesquiterpenoids and their lactones, including α-pinene lactones, guaiacol lactones, and patchoulene lactones with their derivatives. The more abundant components are germacrane, eudesmane, and guaiane type sesquiterpene lactones. These bitter compounds, including taraxacin and taraxacerin, are primarily found in the root. They are responsible for the plant's characteristic bitter taste, which stimulates digestive function by increasing the secretion of saliva, stomach acid, and bile (a cholagogue effect).

Triterpenoids and Phytosterols

Triterpenes, notably taraxerol, along with other pentacyclic triterpenoids like taraxasterol, are predominantly found in the roots, where they form part of the non-volatile fraction. The presence of steroids and triterpenoids, notably sitosterol, stigmasterol, lanosterol, and β-amyrin, has been confirmed by analysis. Compounds like taraxasterol and taraxerol have demonstrated anti-inflammatory properties in preclinical studies.

Polysaccharides — Inulin

The root is the richest source of inulin — a fructose-based polysaccharide that functions as a prebiotic fibre, feeding beneficial bacteria in the gut. Inulin content in the root can reach 40% of dry weight in autumn, declining in spring when the plant mobilises carbohydrate reserves for growth. The root contains no starch, but early in the year contains much uncrystallizable sugar and laevulin, which differs from inulin in being soluble in cold water. This diminishes in quantity during the summer and becomes inulin in the autumn.

Phenolic Acids and Flavonoids

Phenylpropanoids — believed to have inflammation-modulating effects — are present, and hydroxycinnamic acids including chicoric acid, monocaffeyltartaric acid, and chlorogenic acid are found throughout the plant. Three flavonoid glycosides — luteolin-7-glucoside and two luteolin-7-diglucosides — have been isolated from its flowers and leaves. The coumarins cichoriin and aesculin have been identified in leaf extracts.

The phenolic content — specifically chicoric acid, caftaric acid, and chlorogenic acid — and flavonoid content — including apigenin, luteolin, quercetin, isorhamnetin, and kaempferol — vary depending on the plant part and preparation methods.

Potassium and Mineral Content

The leaves have a different phytochemical emphasis. They are exceptionally rich in potassium — up to 4.5% of dry weight — as well as containing significant levels of chicoric acid, chlorogenic acid, and other polyphenols. The high potassium content is pharmacologically relevant because potassium is lost when urinary output increases, and dandelion leaf has been traditionally used as a gentle herbal diuretic.

Additional Compounds

A comprehensive chemical profiling of the dandelion plant using proton nuclear magnetic resonance (¹H NMR) spectroscopy and gas chromatography–mass spectrometry revealed the presence of different amino acids in the whole plant, including alanine, 4-aminobutyrate, arginine, asparagine, carnitine, isoleucine, leucine, phenylalanine, proline, threonine, and valine. In addition to amino acids, several organic acids were identified, such as malic, acetic, citric, and succinic acids, along with glucose-1-phosphate, fructose, mannose, and inositol.

4. Pharmacological Mechanisms of Action

Diuretic Mechanism

The precise mechanism, or even the active constituents, responsible for the diuretic effect of dandelion are not fully known. Unique compounds including eudesmanolide and germacranolide are present in the plant, as well as taraxasterol, which also likely contributes to its physiological effects. Dandelion leaf is exceptionally rich in potassium, and this high potassium content is believed to be a primary reason for its diuretic effect.

Choleretic and Hepatobiliary Mechanisms

The root of the dandelion plant is reported to have diuretic properties and to prevent damage to the liver while stimulating bile flow from the gallbladder due to the presence of sesquiterpene lactones in the root. Dandelion is reported to stimulate the production of bile by the liver (choleretic) and stimulate the flow of bile from the gallbladder into the duodenum (cholagogue). Dandelion plant extracts are also reported to increase the activity of glutathione (GSH) and GSH-related enzymes in the liver, and the long-chain saccharides present in the root may have anti-inflammatory effects.

Preclinical studies have reported that extracts of the plant protect against liver damage induced by toxic agents such as alcohol, carbon tetrachloride, and paracetamol. Among the most relevant and predominant bioactive compounds of T. officinale is taraxasterol, which modulates inflammatory and oxidative stress pathways, helping to prevent liver damage.

Anti-inflammatory Mechanisms

Individual papers describe principal pathways and molecules modulated by Taraxacum in anti-inflammatory activity. Dandelions contain a wide range of bioactive compounds, such as polyphenols, phytosterols, flavonoids, carotenoids, terpenes, and coumarins, some constituents having synergistic activities including anti-inflammatory and antioxidant activities.

Antidiabetic Mechanisms

Research suggests that dandelion extracts may stimulate insulin release from pancreatic β-cells, helping to counteract high blood sugar levels. Plant-based products and compounds have shown promise in managing diabetes through various mechanisms, including inhibiting sugar-digesting enzymes, reducing glucose reabsorption in the kidneys, and influencing glucose metabolism in the liver. Dandelion's antidiabetic properties are attributed to its bioactive compounds, such as phenols, flavonoids, phenolic acids, chicoric acid, taraxasterol, chlorogenic acid, and sesquiterpene lactones.

Molecular docking and MD simulations have validated that quercetin and kaempferol, which demonstrated significant hypoglycemic and antioxidant activities, exhibited particularly strong affinities and stable interactions with α-amylase and α-glucosidase, respectively.

Anticancer Mechanisms

Studies have confirmed the vulnerability of cancer cell mitochondria, showing that dandelion root extract (DRE) treatment led to a decrease in mitochondrial membrane potential and an increase in ROS levels in isolated mitochondria. This was consistent with reports suggesting that the vulnerability of cancer cells' mitochondria stems from altered oxidative phosphorylation and reduced flux through the electron transport chain. DRE-induced destabilization of mitochondrial membranes was also associated with rapid activation of caspase-8.

Prebiotic Activity

Dandelion roots are a powerful source of natural inulin. Several studies have demonstrated the beneficial effects of dandelion extracts on metabolic health, with a link between these metabolic effects being suggested.

5. Scientific Evidence by Area of Use

5.1 Diuretic Activity

Taraxacum officinale has been extensively employed as a diuretic in traditional folk medicine and in modern phytotherapy in Europe, Asia, and the Americas, without prior clinical trial substantiation until a pilot study was conducted. In this pilot study, a high-quality fresh leaf hydroethanolic extract of dandelion was ingested by volunteers to investigate whether increased urinary frequency and volume would result. Volume of urinary output and fluid intake were recorded. Baseline values for urinary frequency and excretion ratio were established two days prior to dandelion dosing (8 mL three times daily) and monitored throughout a one-day dosing period and 24 hours post-dosing. For the entire population (n = 17), there was a significant (p < 0.05) increase in the frequency of urination in the five-hour period after the first dose.

This was only a small pilot study, carried out over a single day using an aqueous-alcoholic extract of fresh dandelion leaf (using a dose of 8 mL three times in the day) on 17 people. It was not a blinded or controlled study. Evidence strength: Weak. A single unblinded pilot study in 17 subjects over one day is insufficient to confirm clinical efficacy. The diuretic indication is currently supported primarily at the traditional-use level.

5.2 Liver Health and Hepatoprotective Effects

Preclinical studies have reported that extracts of dandelion protect against liver damage induced by toxic agents such as alcohol, carbon tetrachloride, and paracetamol. Historically, dandelion has been used to treat various conditions, particularly liver disorders, owing to its antioxidant and anti-inflammatory activities.

Direct hepatic human trial data for dandelion root remain limited, which means the dandelion component is currently supported more strongly by phytochemical and preclinical rationale than by direct liver RCT evidence. While preclinical studies are promising, further clinical trials are essential to confirm the safety and efficacy of T. officinale.

Evidence strength: Preclinical (animal and in vitro) only for hepatoprotection. No controlled human trials directly testing dandelion for liver disease have been published as of the available literature.

5.3 Digestive Function and Appetite

The most directly relevant reference for digestive indications is the EMA community herbal monograph on Taraxacum officinale (dandelion root with herb). Traditional indications describe use for mild digestive symptoms such as fullness, flatulence, and slow digestion, and for temporary appetite loss. The EMA recognizes dandelion as a traditional herbal medicinal product for the relief of symptoms associated with mild digestive disorders (such as a feeling of abdominal fullness, flatulence, and slow digestion) and temporary loss of appetite.

A case series reported on 24 patients with nonspecific chronic colitis treated with a polyherbal formula that included dandelion (T. officinale) alongside St. John's wort, lemon balm, calendula, and fennel. The case series showed a remarkable symptomatic improvement in terms of stool normalization and pain reduction. However, as this was a multi-ingredient preparation, the contribution of dandelion alone cannot be isolated. Evidence strength: Traditional-use level for digestive complaints, supported by official monographs (EMA, ESCOP). Direct clinical evidence for dandelion as a monotherapy for digestive disorders is absent.

5.4 Antidiabetic Effects

Different dandelion root extracts, including aqueous, methanolic, chloroform, ethyl acetate, acetone, and petroleum ester, have been evaluated for their antidiabetic effects in both normal and diabetic mice. Using a multi-target screening approach, 13 dual-target inhibitors were identified from dandelion. At least five of these compounds exhibited anti-diabetic activities comparable to the positive control drug acarbose. Subsequent investigation of the antioxidant capacities of seven of these bioactive compounds revealed that most exhibited more potent antioxidant activities than vitamin C.

Evidence strength: Primarily in vitro and animal model data. No rigorous, controlled human clinical trials specific to dandelion's antidiabetic properties have been identified in the current literature. This remains an area under active preclinical investigation.

5.5 Anticancer Activity

Dandelion is effective as an anticancer agent in laboratory settings, and growing evidence from modern pharmacological research demonstrates notable anticancer effects. Bioactive components from dandelion are effective in inhibiting the occurrence and progression of various cancers, such as breast, lung, and liver cancers in cell studies.

Dandelion root extract demonstrated anticancer effects against melanoma and leukemia, as well as pancreatic and colorectal cancer cell lines. However, the anticancer properties of dandelion extracts have only been the subject of a few scientific investigations, and more needs to be understood about the mechanism of action.

Preclinical studies suggest increased proliferation of hormone-sensitive breast cancer cells as well as increased uterine weight in immature female rats. This finding is a notable preclinical signal of potential estrogenic activity that warrants attention.

Evidence strength: Preclinical (cell line and animal) only. There are no published controlled human clinical trials on dandelion for cancer treatment or prevention. Findings are exploratory and hypothesis-generating.

5.6 Antioxidant Activity

A comprehensive review searching the PubMed database and selecting 54 studies described twelve therapeutic properties, including antioxidant effects. The most frequently reported therapeutic effects include hepatoprotective, antioxidant, and anticancer activities.

Dandelions contain a wide range of bioactive compounds, such as polyphenols, phytosterols, flavonoids, carotenoids, terpene, and coumarins, some constituents having synergistic antioxidant activities. Evidence strength: Antioxidant capacity is well-established in vitro, and is considered a plausible mechanism contributing to multiple other effects. Controlled human trials specifically investigating antioxidant outcomes are limited.

5.7 Anti-inflammatory Activity

In vitro and in vivo studies suggest that dandelion has anti-inflammatory and antioxidant activities. The sesquiterpene lactones and triterpene compounds (particularly taraxasterol) are regarded as primary mediators of these effects based on preclinical data. Apart from diuresis, these effects include liver stimulant (laxative), anti-inflammatory, anti-oxidant, anti-carcinogenic, pain-killing, blood-glucose modulating, and blood-thinning properties. There is increasing laboratory research evidence for these effects, but sadly no human trials for a variety of traditional applications of the herb including liver and gallbladder problems, breast diseases, digestive problems, joint pain, fever, and skin diseases.

Evidence strength: Preclinical (in vitro and animal) only for direct anti-inflammatory effects. No controlled human trials have been identified.

5.8 Lipid and Metabolic Effects

In vitro and in vivo studies suggest that dandelion has lipid-lowering activity. Polyphenolic compounds such as chicoric acid inhibit pancreatic lipase, indirectly supporting weight management by limiting dietary fat absorption in preclinical models. Evidence strength: Preclinical only. Human evidence is absent.

6. Body Systems and Health Areas Associated with Dandelion

• Hepatobiliary system: Choleretic and cholagogue effects (bile production and flow stimulation), hepatoprotection against toxic liver injury — preclinical evidence; traditional use recognized by ESCOP.
• Urinary system: Diuresis and urinary tract flushing — single small human pilot study; traditional use recognized by EMA.
• Gastrointestinal system: Relief of mild dyspepsia, flatulence, fullness, temporary appetite loss — traditional use recognized by EMA and ESCOP.
• Metabolic / endocrine: Antidiabetic potential (enzyme inhibition, insulin secretagogue effects) — preclinical only.
• Antioxidant defense: Free radical scavenging via polyphenols and flavonoids — well established in vitro.
• Oncology (investigational): Pro-apoptotic and anti-proliferative effects against multiple cancer cell lines — preclinical cell and animal data only.
• Gut microbiome: Prebiotic inulin activity supporting beneficial gut bacteria — established for inulin class compounds, extrapolated to dandelion root.
• Cardiovascular / lipid: Lipid-lowering activity — preclinical only.

7. Dosage Forms and Reported Dosages

The following dosages are as reported in official monographs and clinical/traditional reference sources only.

Fresh Leaf Juice (Expressed Juice)

For adolescents (12–17 years) and adults (18 years and older): 10–20 milliliters of juice of fresh leaf per day, not to exceed 10 milliliters per single dose (EMA 2009; BHC 1992).

Fresh Root Juice

12–24 milliliters of juice of fresh root per day, not to exceed 8 milliliters per single dose (BHC 1992; BHP 1983).

Fresh Whole Plant Juice

15–30 milliliters of juice of fresh whole plant per day, not to exceed 10 milliliters per single dose (EMA 2009; Blumenthal et al. 2000).

Adequate Fluid Intake

To ensure an increase of the amount of urine, adequate fluid intake is required during treatment (EMA 2009). Intended for occasional use only.

Dosage in the Human Diuretic Pilot Study

In the published 2009 pilot study, dosing of a fresh leaf hydroethanolic extract was 8 mL administered three times per day, with baseline values established over two days prior to dosing and monitoring continuing for 24 hours post-dosing.

EMA-Recognized Preparation Specifications

The EMA community herbal monograph for dandelion leaf specifies: dried leaves (comminuted), liquid extract (DER 1:1) in ethanol 25% (V/V), and expressed juice from fresh leaves. For dandelion root with herb, recognized preparations include a dry extract with DER 5.6–8.4:1 in ethanol 60%, liquid extracts in ethanol 30%, and expressed juice with DER 1:0.5–0.8.

8. Safety Considerations and Drug Interactions

General Safety

The use of dandelion in the amounts commonly found in food is considered likely safe. Less is known about the safety of taking dandelion in larger amounts. Research on dandelion is limited, and its benefits and risks are not well defined. Common side effects may include diarrhea, indigestion, or upset stomach.

Allergy and Asteraceae Cross-Reactivity

Dandelion can cause allergic reactions when taken by mouth or applied to the skin of sensitive individuals. People who are allergic to ragweed and related plants (daisies, chrysanthemums, marigolds) are likely to be allergic to dandelion. Sesquiterpene lactones are also responsible for the allergenic potential of dandelion. The stems contain a milky latex that may cause a rash in individuals with latex sensitivities or those allergic to the Asteraceae family.

Gallbladder and Bile Duct Disease

Dandelion is known to stimulate bile production, which can be beneficial for digestion and liver health in healthy individuals. However, for those with gallbladder disease, gallstones, or bile duct obstruction, increased bile production can exacerbate symptoms and lead to complications such as pain, inflammation, or blockages.

Kidney Disease

Dandelion might reduce how much oxalate is released through urine. In theory, this might increase the risk for complications in people with kidney problems.

Drug Interactions

There are theoretical reasons to suspect that dandelion might interact with antidiabetes, anticoagulant, antiplatelet, and water pill drugs, among others.

• Diuretics: Dandelion is a mild natural diuretic. Combining with prescription diuretics (furosemide, hydrochlorothiazide) may cause dehydration or electrolyte imbalance.
• Antihypertensives: Mixing with antihypertensives (ACE inhibitors, beta-blockers) can amplify the effect, risking dizziness or hypotension.
• Antidiabetes drugs: When combined with insulin or metformin, dandelion could lead to hypoglycemia.
• Anticoagulants/Vitamin K: Dandelion contains vitamin K, which may interfere with warfarin or other anticoagulants.
• Lithium: Dandelion might have an effect like a water pill or "diuretic," and taking dandelion might decrease how well the body gets rid of lithium. This could increase how much lithium is in the body and result in serious side effects.
• Quinolone antibiotics: Dandelion might decrease how much antibiotic the body absorbs. Taking dandelion along with certain antibiotics might decrease the effectiveness of these antibiotics. Some antibiotics that might interact with dandelion include ciprofloxacin (Cipro), enoxacin, norfloxacin, sparfloxacin, trovafloxacin, gatifloxacin, levofloxacin, lomefloxacin, moxifloxacin, ofloxacin, and grepafloxacin.
• Hepatically metabolized drugs: Dandelion might increase how quickly some medications are broken down by the liver, which could decrease how well some of these medications work. Some medications affected include acetaminophen (Tylenol), atorvastatin (Lipitor), diazepam (Valium), digoxin, estrogen preparations, irinotecan (Camptosar), lamotrigine (Lamictal), lovastatin (Mevacor), morphine, and others.

Pregnancy and Breastfeeding

Little is known about whether it's safe to use dandelion in amounts greater than those found in foods during pregnancy or while breastfeeding.

Pediatric Use

Dandelion should not be administered to children under the age of 18 because its safety has not been established in children.

References

• Wang et al. (2026). Bioactive Compounds from Dandelion (Taraxacum officinale): Advances in Extraction Techniques and Applications. Foods, MDPI.
• Lepadatu et al. (2025). Bioactive Compounds from Vegetal Organs of Taraxacum Species (Dandelion) with Biomedical Applications: A Review. Int. J. Mol. Sci. PMC.
• Yan et al. (2024). The phytochemical and pharmacological profile of dandelion. Biomedicine & Pharmacotherapy. ScienceDirect.
• Bentham Science Publishers. Dandelion (Taraxacum officinale): A Promising Source of Nutritional and Therapeutic Compounds. PubMed.
• Pirożnikow et al. (2025). Multilateral Use of Dandelion in Folk Medicine of Central-Eastern Europe. PMC.
• Clare BA, Conroy RS, Spelman K. (2009). The diuretic effect in human subjects of an extract of Taraxacum officinale folium over a single day. PubMed (PMID: 19678785).
• Mancebo-Campos et al. (2025). The Role of Dandelion (Taraxacum officinale) in Liver Health and Hepatoprotective Properties. PMC.
• Wirngo et al. (2021). A comprehensive review of the benefits of Taraxacum officinale on human health. Bulletin of the National Research Centre. Springer Nature.
• National Center for Complementary and Integrative Health (NCCIH). Dandelion: Usefulness and Safety. NIH.
• European Medicines Agency (EMA). Community Herbal Monograph on Taraxacum officinale Weber ex Wigg., folium. EMA/HMPC/579636/2008.
• European Medicines Agency (EMA). Community Herbal Monograph on Taraxacum officinale Weber ex Wigg., radix cum herba. EMA/HMPC/212895/2008.
• Health Canada Natural Health Products Ingredients Database. Dandelion – Taraxacum officinale.
• Health Canada Natural Health Products Ingredients Database. Dandelion Juice – Taraxacum officinale.
• Wang A et al. (2025). Tracking Evidences of Dandelion for the Treatment of Cancer. PMC.
• Ovadje P et al. (2016). Dandelion root extract affects colorectal cancer proliferation and survival through the activation of multiple death signalling pathways. PMC.
• Zhuang X et al. (2025). Multi-Target Screening of Anti-Diabetic and Antioxidant Potential Bioactive Constituents from Dandelion. PMC.
• Memorial Sloan Kettering Cancer Center. Dandelion – Integrative Medicine Herb Summary.
• RxList. Dandelion: Health Benefits, Side Effects, Uses, Dose & Precautions.
• National Library of Medicine Historical Collections. The Dandelion. Circulating Now.
• Schütz K et al. Dandelion: Phytochemistry and clinical potential. Plants Journal.
• Dandelion (Taraxacum officinale) as a prebiotic source: implications for gut microbiota, metabolic health, and functional food development. International Journal of Food Science and Technology. Oxford Academic.
• Antioxidant and antimicrobial activities of Dandelion root extract (Taraxacum officinale) and its cytotoxic effect on MDA-MB-231 breast cancer cells. Discover Applied Sciences. Springer Nature.